Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) CEO Joel Latham tells Proactive the company has appointed two highly experienced lead principal investigators.
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) has appointed two highly experienced lead principal investigators (PIs) for its Phase 2/3 clinical trial of.
Week in review: ASX rallies; New Zealand enters a technical recession; European central bank hikes rates proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.